American Century Companies’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.1M | Sell |
2,425,722
-13,717
| -0.6% | -$142K | 0.01% | 1182 |
|
|
2025
Q4 | $30.2M | Buy |
2,439,439
+57,061
| +2% | +$611K | 0.02% | 957 |
|
|
2025
Q3 | $21M | Buy |
2,382,378
+90,216
| +4% | +$702K | 0.01% | 1128 |
|
|
2025
Q2 | $14.6M | Sell |
2,292,162
-5,459
| -0.2% | -$31.2K | 0.01% | 1224 |
|
|
2025
Q1 | $11.2M | Buy |
2,297,621
+159,909
| +7% | +$1.32M | 0.01% | 1288 |
|
|
2024
Q4 | $20.4M | Buy |
2,137,712
+404,667
| +23% | +$3.71M | 0.01% | 1032 |
|
|
2024
Q3 | $14.5M | Buy |
1,733,045
+851,152
| +97% | +$7.74M | 0.01% | 1168 |
|
|
2024
Q2 | $6.01M | Buy |
881,893
+623,201
| +241% | +$2.68M | ﹤0.01% | 1443 |
|
|
2024
Q1 | $654K | Buy |
258,692
+166,738
| +181% | +$376K | ﹤0.01% | 2328 |
|
|
2023
Q4 | $221K | Sell |
91,954
-207,689
| -69% | -$488K | ﹤0.01% | 2662 |
|
|
2023
Q3 | $1.02M | Sell |
299,643
-65,147
| -18% | -$361K | ﹤0.01% | 1982 |
|
|
2023
Q2 | $2.68M | Buy |
364,790
+1,668
| +0.5% | +$15.5K | ﹤0.01% | 1549 |
|
|
2023
Q1 | $3.7M | Sell |
363,122
-4,964
| -1% | -$60K | ﹤0.01% | 1366 |
|
|
2022
Q4 | $4.35M | Buy |
368,086
+24,868
| +7% | +$385K | ﹤0.01% | 1272 |
|
|
2022
Q3 | $7.2M | Buy |
343,218
+18,357
| +6% | +$511K | 0.01% | 999 |
|
|
2022
Q2 | $10.1M | Buy |
324,861
+122,515
| +61% | +$4.18M | 0.01% | 900 |
|
|
2022
Q1 | $8.31M | Buy |
202,346
+43,471
| +27% | +$1.92M | 0.01% | 962 |
|
|
2021
Q4 | $6.91M | Buy |
158,875
+110,759
| +230% | +$5.01M | ﹤0.01% | 980 |
|
|
2021
Q3 | $2.41M | Sell |
48,116
-2,024
| -4% | -$123K | ﹤0.01% | 1241 |
|
|
2021
Q2 | $3.16M | Buy |
50,140
+7,761
| +18% | +$499K | ﹤0.01% | 1096 |
|
|
2021
Q1 | $3.94M | Buy |
42,379
+39,464
| +1,354% | +$4.04M | ﹤0.01% | 998 |
|
|
2020
Q4 | $261K | Sell |
2,915
-8,367
| -74% | -$768K | ﹤0.01% | 1776 |
|
|
2020
Q3 | $1.17M | Buy |
+11,282
| New | +$1.22M | ﹤0.01% | 1096 |
|
|
2020
Q1 | – | Sell |
-38,419
| Closed | -$2.07M | – | 1636 |
|
|
2019
Q4 | $2.07M | Sell |
38,419
-41,292
| -52% | -$2.24M | ﹤0.01% | 929 |
|
|
2019
Q3 | $4.17M | Buy |
+79,711
| New | +$3.71M | ﹤0.01% | 836 |
|
|
2019
Q1 | – | Sell |
-88,286
| Closed | -$5.23M | – | 1251 |
|
|
2018
Q4 | $5.23M | Buy |
88,286
+21,334
| +32% | +$1.38M | 0.01% | 790 |
|
|
2018
Q3 | $4.41M | Sell |
66,952
-19,964
| -23% | -$1.16M | ﹤0.01% | 884 |
|
|
2018
Q2 | $4.39M | Buy |
86,916
+69,445
| +397% | +$3.62M | ﹤0.01% | 876 |
|
|
2018
Q1 | $920K | Buy |
17,471
+490
| +3% | +$24.4K | ﹤0.01% | 1095 |
|
|
2017
Q4 | $789K | Buy |
+16,981
| New | +$715K | ﹤0.01% | 1126 |
|
|
2016
Q3 | – | Sell |
-180,590
| Closed | -$5.08M | – | 1354 |
|
|
2016
Q2 | $5.08M | Buy |
180,590
+2,533
| +1% | +$99.3K | 0.01% | 836 |
|
|
2016
Q1 | $6.47M | Buy |
178,057
+5,229
| +3% | +$185K | 0.01% | 754 |
|
|
2015
Q4 | $6.92M | Sell |
172,828
-31,090
| -15% | -$1.08M | 0.01% | 729 |
|
|
2015
Q3 | $5.81M | Buy |
203,918
+22,064
| +12% | +$727K | 0.01% | 784 |
|
|
2015
Q2 | $5.99M | Buy |
181,854
+7,795
| +4% | +$242K | 0.01% | 781 |
|
|
2015
Q1 | $5.01M | Sell |
174,059
-18,007
| -9% | -$516K | 0.01% | 837 |
|
|
2014
Q4 | $5.23M | Buy |
192,066
+6
| +0% | +$143 | 0.01% | 841 |
|
|
2014
Q3 | $4.09M | Buy |
192,060
+15,371
| +9% | +$352K | ﹤0.01% | 925 |
|
|
2014
Q2 | $3.97M | Buy |
176,689
+9,318
| +6% | +$217K | ﹤0.01% | 961 |
|
|
2014
Q1 | $4.23M | Buy |
167,371
+103,252
| +161% | +$2.61M | 0.01% | 960 |
|
|
2013
Q4 | $1.47M | Buy |
+64,119
| New | +$1.34M | ﹤0.01% | 1178 |
|
Other funds holding EBS
VCM
PCM
VPM
OHA
American Century Companies's EBS Position: Q1 2026 in Review
American Century Companies reduced its Emergent Biosolutions (EBS) stake by 0.56% in Q1 2026, selling an estimated $142K and leaving 2,425,722 shares worth $20.1M. The position accounts for 0.01% of the portfolio, ranked #1182.
American Century Companies first reported a position in EBS in Q4 2013 and has held it in 41 quarters since. The position peaked at $30.2M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- American Century Companies held 2,425,722 shares of Emergent Biosolutions worth $20.1M as of Q1 2026.
- American Century Companies sold 13,717 Emergent Biosolutions shares in Q1 2026, an estimated $142K.
- Emergent Biosolutions made up 0.01% of American Century Companies's portfolio in Q1 2026, its #1182 holding.
- American Century Companies first reported a position in Emergent Biosolutions in Q4 2013 and has held it in 41 quarters since.
- American Century Companies's Emergent Biosolutions position peaked at $30.2M in Q4 2025.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.